Correction: Overexpressing TGF-β1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven
Stem Cell Research & Therapy volume 13, Article number: 362 (2022)
Correction to: Stem Cell Research & Therapy (2020) 11:378 https://doi.org/10.1186/s13287-020-01894-2
The original article  contains a number of errors which the authors would like to clarify:
Fig. 3F: Spleen: MSC-TGF-β1 was misplaced, and now corrected
In the Materials and Methods section under the sub-heading “CLP model of sepsis”, the term, ‘5% chloral hydrate (400 mg/kg)’ should be pentobarbital (50 mg/kg), this can be seen in the first draft submitted to the journal. Correction made is listed below.
The sepsis model was induced via the CLP method. Briefly, the mice were anaesthetized with pentobarbital (50 mg/kg) by intraperitoneal injection, and their lower abdomen was then shaved.
In the section of ethics approval and consent to participate: All of the experimental procedures were approved by the Southeast University Ethics Committee (protocol number: 20171101006).
These corrections will not affect the result and scientific conclusion of the manuscript. The authors would like to apologize for any inconvenience caused.
Liu F, et al. Overexpressing TGF-β1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven inflammation. Stem Cell Res Ther. 2020;11:378. https://doi.org/10.1186/s13287-020-01894-2.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Liu, F., Xie, J., Zhang, X. et al. Correction: Overexpressing TGF-β1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven. Stem Cell Res Ther 13, 362 (2022). https://doi.org/10.1186/s13287-022-03078-6